昔日大牛股获全球顶级车企定点通知书

Group 1 - Kingoo Co., Ltd. received a 10-year long-term order from a global leading automotive company to develop wheel products for American passenger cars, with expected sales of approximately $158 million over the first five years [1] - Shanghai Xiba plans to acquire several patents from the Chinese Academy of Sciences for a total of 2.5 million yuan and establish two subsidiaries to promote technology commercialization [2] - Sichuan Gold announced that two major shareholders plan to reduce their stakes by 2.5% and 3% respectively, citing personal funding needs [3] Group 2 - Yitian Co. intends to acquire 40% of its subsidiary Yitian Semiconductor for 1 yuan, increasing its ownership to 100% [6] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% within three months due to operational needs [7] - Longqi Technology is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance capital strength and international competitiveness [9] Group 3 - Kexing Pharmaceutical received FDA approval for clinical trials of its innovative drug GB18 injection in the U.S., targeting cancer cachexia [19] - Lisheng Pharmaceutical's subsidiary will receive a cash dividend of 304 million yuan from its investment in Tian Shili Biological [21] - Shanghai Laishi's controlling shareholder plans to increase its stake in the company by 250 million to 500 million yuan to boost investor confidence [22]